OTCMKTS:JBPHF Jacobio Pharmaceuticals Group (JBPHF) Stock Price, News & Analysis $0.30 0.00 (0.00%) As of 07/25/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartShort InterestBuy This Stock About Jacobio Pharmaceuticals Group Stock (OTCMKTS:JBPHF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get JBPHF alerts:Sign Up Key Stats Today's Range$0.30▼$0.3050-Day Range$0.30▼$0.3052-Week Range$0.30▼$0.30VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Jacobio Pharmaceuticals Group Co., Ltd. is a China-based biopharmaceutical company engaged in the discovery, development and commercialization of novel therapies for oncology and immuno-oncology indications. The company’s research efforts focus on small‐molecule inhibitors and biologics designed to address solid tumor types including lung, liver and esophageal cancers. Jacobio’s pipeline features multiple preclinical and clinical‐stage candidates targeting specific molecular pathways and tumor microenvironment interactions. Operating research and development facilities in Shanghai, Jacobio collaborates with academic institutions, contract research organizations and clinical sites across Mainland China. The company has advanced several investigational new drug (IND) applications with Chinese regulatory authorities and is exploring the potential for international clinical trials and regulatory filings in Asia-Pacific markets. Its scientific platform integrates medicinal chemistry, translational biology and immuno-oncology expertise to accelerate candidate selection and development. Supported by a management team with extensive experience in pharmaceutical R&D, regulatory affairs and strategic alliances, Jacobio Pharmaceuticals is pursuing partnerships and in-licensing opportunities to broaden its therapeutic portfolio. The company aims to bring first-in-class or best-in-class treatments to patients by leveraging its targeted therapy and immunotherapeutic technologies.AI Generated. May Contain Errors. Read More Receive JBPHF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Jacobio Pharmaceuticals Group and its competitors with MarketBeat's FREE daily newsletter. Email Address JBPHF Stock News HeadlinesJacobio Pharmaceuticals Increases Concert Parties’ ShareholdingsJuly 23 at 6:32 PM | tipranks.comJacobio Pharmaceuticals Sees Increased Shareholdings by Concert PartiesJuly 20, 2025 | tipranks.comTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trillions in oil, gas, lithium, and land rights. Whitney Tilson breaks it all down, and shows how everyday Americans can grab a stake. His urgent new briefing explains "The US: IPO"... and how to get in before the looming federal deadline.July 26 at 2:00 AM | Stansberry Research (Ad)Jacobio's IND for Phase I/II Clinical Trial of BET Inhibitor JAB-8263 in Autoimmune Diseases has been AcceptedJuly 2, 2025 | prnewswire.comJacobio’s KRAS G12C Inhibitor Glecirasib Gains Approval for Market LaunchMay 22, 2025 | tipranks.comJacobio’s SHP2 Inhibitor Sitneprotafib Gains Recognition in Cancer ResearchMay 8, 2025 | tipranks.comJacobio Pharmaceuticals Advances Cancer Drug Pipeline with Strategic Licensing and TrialsMarch 19, 2025 | tipranks.comJacobio’s KRAS Inhibitor Glecirasib Shows Promising Trial ResultsJanuary 6, 2025 | tipranks.comSee More Headlines JBPHF Stock Analysis - Frequently Asked Questions How have JBPHF shares performed this year? Jacobio Pharmaceuticals Group's stock was trading at $0.2950 at the beginning of 2025. Since then, JBPHF shares have increased by 0.0% and is now trading at $0.2950. How do I buy shares of Jacobio Pharmaceuticals Group? Shares of JBPHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:JBPHF CIKN/A Webwww.jacobiopharma.com Phone86-10-5631-5466FaxN/AEmployees301Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (OTCMKTS:JBPHF) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jacobio Pharmaceuticals Group Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jacobio Pharmaceuticals Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.